Cover Image
Market Research Report
Product code 
1093021

LAMEA Preimplantation Genetics Diagnosis (PGD) Market Size, Share & Industry Trends Analysis Report By Test Type (Aneuploidy, Chromosomal Abnormalities, X-linked diseases), By Country and Growth Forecast, 2022 - 2028

Published: | KBV Research | 64 Pages | Delivery time: 1-2 business days

Price

Back to Top
LAMEA Preimplantation Genetics Diagnosis (PGD) Market Size, Share & Industry Trends Analysis Report By Test Type (Aneuploidy, Chromosomal Abnormalities, X-linked diseases), By Country and Growth Forecast, 2022 - 2028
Published: April 29, 2022
KBV Research
Content info: 64 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Latin America, Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market would witness market growth of 15.9% CAGR during the forecast period (2022-2028).

PGD's great accuracy in detecting genetic abnormalities boosted its commercial popularity. Additionally, the industry is being propelled forward by an increase in expenditure for the diagnosis of genetic disorders and chromosomal anomalies around the world. Furthermore, the growing awareness of the benefits of PGD across developing countries represents a significant preimplantation genetics diagnosis market opportunity.

The growing awareness of preimplantation genetic testing among persons with genetic disorders is propelling the global Preimplantation Genetic Testing Market. The Preimplantation Genetic Testing Market is expected to develop significantly due to the increasing availability of medical knowledge and the predominance of technologically improved genetic devices. Furthermore, the rising demand for preimplantation diagnostic and screening techniques is linked to the rising incidence of single gene, mitochondrial, and other gene-related illnesses. PGD is recommended in IVF cycles for women who have had numerous miscarriages or whose most recent pregnancy had a chromosomal issue.

Although preimplantation genetic diagnosis (PGD) (now known as PGT-M) has been around since 1990, it is still a very new and limited service in South Africa (SA), a low-to-middle-income nation (LMIC). In 2006, our South African academic and diagnostic Human Genetics Unit managed the first known PGD case. Over time, the PGD procedure has changed, with substantial modifications in the timing of embryo biopsy and the tools used.

Private medical insurance covers approximately 17.4% of the population in South Africa, but it typically does not cover the cost of PGD, forcing couples to pay for the operation themselves. The remaining 82.6 percent of the population is reliant on the government-run healthcare system, which currently does not provide PGD. The high cost of PGD, combined with a lack of medical insurance coverage, is a limiting factor in the area, making it only available to a select group of people with higher socioeconomic levels.

The Brazil market dominated the LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3.5 million by 2028. The Argentina market is estimated to grow at a CAGR of 16.5% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 15.6% during (2022 - 2028).

Based on Test Type, the market is segmented into Aneuploidy, Chromosomal Abnormalities, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Invitae Corporation, Natera, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Reproductive Genetic Innovations, PacGenomics, CeGaT GmbH, and Laboratory Corporation of America Holdings.

Scope of the Study

Market Segments covered in the Report:

By Test Type

  • Aneuploidy
  • Chromosomal Abnormalities
  • X-linked diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Illumina, Inc.
  • Invitae Corporation
  • Natera, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations
  • PacGenomics
  • CeGaT GmbH
  • Laboratory Corporation of America Holdings

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Preimplantation Genetics Diagnosis (PGD) Market, by Test Type
    • 1.4.2 LAMEA Preimplantation Genetics Diagnosis (PGD) Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type

  • 3.1 LAMEA Aneuploidy Market by Country
  • 3.2 LAMEA Chromosomal Abnormalities Market by Country
  • 3.3 LAMEA X-linked diseases Market by Country
  • 3.4 LAMEA Single Gene Disorders Market by Country
  • 3.5 LAMEA HLA Typing Market by Country
  • 3.6 LAMEA Gender selection Market by Country
  • 3.7 LAMEA Other Test Type Market by Country

Chapter 4. LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country

  • 4.1 Brazil Preimplantation Genetics Diagnosis (PGD) Market
    • 4.1.1 Brazil Preimplantation Genetics Diagnosis (PGD) Market by Test Type
  • 4.2 Argentina Preimplantation Genetics Diagnosis (PGD) Market
    • 4.2.1 Argentina Preimplantation Genetics Diagnosis (PGD) Market by Test Type
  • 4.3 UAE Preimplantation Genetics Diagnosis (PGD) Market
    • 4.3.1 UAE Preimplantation Genetics Diagnosis (PGD) Market by Test Type
  • 4.4 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market
    • 4.4.1 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
  • 4.5 South Africa Preimplantation Genetics Diagnosis (PGD) Market
    • 4.5.1 South Africa Preimplantation Genetics Diagnosis (PGD) Market by Test Type
  • 4.6 Nigeria Preimplantation Genetics Diagnosis (PGD) Market
    • 4.6.1 Nigeria Preimplantation Genetics Diagnosis (PGD) Market by Test Type
  • 4.7 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market
    • 4.7.1 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type

Chapter 5. Company Profiles

  • 5.1 Illumina, Inc.
    • 5.1.1 Company Overview
    • 5.1.2 Financial Analysis
    • 5.1.3 Regional Analysis
    • 5.1.4 Research & Development Expense
  • 5.2 Invitae Corporation
    • 5.2.1 Company Overview
    • 5.2.2 Financial Analysis
    • 5.2.3 Regional Analysis
    • 5.2.4 Research & Development Expenses
  • 5.3 Natera Inc.
    • 5.3.1 Company Overview
    • 5.3.2 Financial Analysis
    • 5.3.3 Regional Analysis
    • 5.3.4 Research & Development Expenses
  • 5.4 Agilent Technologies, Inc.
    • 5.4.1 Company Overview
    • 5.4.2 Financial Analysis
    • 5.4.3 Segmental and Regional Analysis
    • 5.4.4 Research & Development Expense
    • 5.4.5 Recent Strategies and Developments:
      • 5.4.5.1 Approvals and Trials:
  • 5.5 PerkinElmer, Inc.
    • 5.5.1 Company Overview
    • 5.5.2 Financial Analysis
    • 5.5.3 Segmental and Regional Analysis
    • 5.5.4 Research & Development Expense
    • 5.5.5 Recent Strategies and Developments:
      • 5.5.5.1 Product Launches and Product Expansions:
  • 5.6 Quest Diagnostics Incorporated
    • 5.6.1 Company Overview
    • 5.6.2 Financial Analysis
    • 5.6.3 Segmental Analysis
  • 5.7 Reproductive Genetic Innovations
    • 5.7.1 Company Overview
  • 5.8 PacGenomics
    • 5.8.1 Company Overview
  • 5.9 CeGaT GmbH
    • 5.9.1 Company Overview
  • 5.10. Laboratory Corporation of America Holdings
    • 5.10.1 Company Overview
    • 5.10.2 Financial Analysis
    • 5.10.3 Segmental and Regional Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 2 LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 3 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 4 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 5 LAMEA Aneuploidy Market by Country, 2018 - 2021, USD Thousands
  • TABLE 6 LAMEA Aneuploidy Market by Country, 2022 - 2028, USD Thousands
  • TABLE 7 LAMEA Chromosomal Abnormalities Market by Country, 2018 - 2021, USD Thousands
  • TABLE 8 LAMEA Chromosomal Abnormalities Market by Country, 2022 - 2028, USD Thousands
  • TABLE 9 LAMEA X-linked diseases Market by Country, 2018 - 2021, USD Thousands
  • TABLE 10 LAMEA X-linked diseases Market by Country, 2022 - 2028, USD Thousands
  • TABLE 11 LAMEA Single Gene Disorders Market by Country, 2018 - 2021, USD Thousands
  • TABLE 12 LAMEA Single Gene Disorders Market by Country, 2022 - 2028, USD Thousands
  • TABLE 13 LAMEA HLA Typing Market by Country, 2018 - 2021, USD Thousands
  • TABLE 14 LAMEA HLA Typing Market by Country, 2022 - 2028, USD Thousands
  • TABLE 15 LAMEA Gender selection Market by Country, 2018 - 2021, USD Thousands
  • TABLE 16 LAMEA Gender selection Market by Country, 2022 - 2028, USD Thousands
  • TABLE 17 LAMEA Other Test Type Market by Country, 2018 - 2021, USD Thousands
  • TABLE 18 LAMEA Other Test Type Market by Country, 2022 - 2028, USD Thousands
  • TABLE 19 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country, 2018 - 2021, USD Thousands
  • TABLE 20 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country, 2022 - 2028, USD Thousands
  • TABLE 21 Brazil Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 22 Brazil Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 23 Brazil Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 24 Brazil Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 25 Argentina Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 26 Argentina Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 27 Argentina Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 28 Argentina Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 29 UAE Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 30 UAE Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 31 UAE Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 32 UAE Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 33 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 34 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 35 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 36 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 37 South Africa Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 38 South Africa Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 39 South Africa Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 40 South Africa Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 41 Nigeria Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 42 Nigeria Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 43 Nigeria Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 44 Nigeria Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 45 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
  • TABLE 46 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
  • TABLE 47 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
  • TABLE 48 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
  • TABLE 49 key information - Illumina, Inc.
  • TABLE 50 Key Information - Invitae Corporation
  • TABLE 51 Key Information - Natera Inc.
  • TABLE 52 key Information - Agilent Technologies, Inc.
  • TABLE 53 key Information - PerkinElmer, Inc.
  • TABLE 54 Key information - Quest Diagnostics Incorporated
  • TABLE 55 Key information - Reproductive Genetic Innovations
  • TABLE 56 Key Information - PacGenomics
  • TABLE 57 key information - CeGaT GmbH
  • TABLE 58 Key Information - Laboratory Corporation of America holdings

List of Figures

  • FIG 1 Methodology for the research